PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1358173
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1358173
The global medical device coating market is estimated to be valued at US$ 13.60 billion in 2023 and is expected to exhibit a CAGR of 8.9% during the forecast period (2023-2030).
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2022 | Market Size in 2023: | US$ 13.60 Bn |
Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
Forecast Period 2023 to 2030 CAGR: | 8.90% | 2030 Value Projection: | US$ 24.70 Bn |
Medical device coatings are specialized coatings used in the medical industry to enhance the performance, durability, and safety of various medical devices and equipment. These coatings are designed to protect medical devices, such as surgical instruments, implants, catheters, and stents, from damage and wear and tear caused by harsh medical environments and the patient's body's natural processes.
Implantable medical devices are used in a variety of applications, including bone substitutes and materials, vascular grafts, stents for peripheral and neurovascular use, and implants designed solely for long-term drug release. The device can be made of metal, metal alloys, polymers, ceramics, and other biocompatible materials. The cells offer biocompatibility and non-toxicity. The device is intended for contact with blood and does not contain thrombosis. Coating the device with a larger portion of the coating solution, which can result in better vascular coagulation to reciprocate the outer diameter.
Medical devices should be able to measure excellent delivery free of charge to develop a coating solution process. Medical devices are widely used in modern healthcare. It is designed to be implanted or inserted into the human body and must be biocompatible. Some devices are often partially composed of metal alloys but must be coated with a biocompatible or hemicompatible coating of a polymer-based material that prevents thrombus formation, improves wettability, and promotes endothelialization.
The key market players in the medical device coating are focused on investment strategies, which in turn is expected to propel market growth over the forecast period. For instance, in November 2023, GTCR, a leading private equity firm, announced that it had made a strategic, majority investment in hydrophilic biomaterial coatings for medical devices in Biocoat Holdings, LLC, a provider of medical device coatings, to support the growth and expansion of a biocompatible medical device coatings provider.
Furthermore, market players are focused on launching new products in the market, which in turn is expected to boost market growth over the forecast period. For instance, in April 2022, BioInteractions, a UK biomaterial technology company, announced the launch of TridAnt, a new coating technology for medical devices that represents a paradigm shift in infection prevention and protection against a broad range of pathogens.